|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.15 EUR | +0.90% |
|
+3.57% | -9.06% |
| 06-12 | Euronext includes Maurel et Prom, Mersen in SBF 120, excludes Elior Group, Nexity | RE |
| 06-04 | Neurones S.A.'s Equity Buyback announced on October 21, 2025, has expired. | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | 52 | +34.02% | 1 | ||||
| 244.16 | +3.83% | 23 | ||||||
| 302.29 | -4.57% | 48 | ||||||
| 178.89 | +4.96% | 25 | ||||||
| 2,491.93 | +1.3% | 42 | ||||||
| 33.91 | +25.6% | 16 | ||||||
| 1,201.29 | +2.89% | 42 | ||||||
| 1,268.42 | -7.41% | 40 | ||||||
| 5,949.17 | +29.39% | 12 | ||||||
| 4,589.23 | +33.56% | 13 | ||||||
| 29.71 | +18.99% | 15 | ||||||
| 67.5 | +19.46% | 21 | ||||||
| 318 | +6.28% | 5 | ||||||
| 129.02 | -12.72% | 42 | ||||||
| 64.1 | +14.2% | 25 | ||||||
| 436.1 | +5.79% | 10 | ||||||
| 139.63 | +30% | 17 | ||||||
| 835,909.09 | +61.37% | 11 | ||||||
| 177.75 | -4.95% | 40 | ||||||
| Average | 44,925.38 | +13.79% | 24 | ||||||
| Weighted average by Cap. | 17,833.54 | +8.27% | 28 |
- Stock Market
- Stocks
- NRO Stock
- Sector NEURONES
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
